These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12667713)

  • 1. Recent trends in prostate cancer incidence and mortality in southeast England.
    Evans HS; Møller H
    Eur Urol; 2003 Apr; 43(4):337-41. PubMed ID: 12667713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinicopathologic patterns of prostatic diseases and prostate cancer in Saudi patients.
    Mosli HA; Abdel-Meguid TA; Al-Maghrabi JA; Kamal WK; Saadah HA; Farsi HM
    Saudi Med J; 2009 Nov; 30(11):1439-43. PubMed ID: 19882057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in Prostate Specific Antigen (PSA) testing and prostate cancer incidence and mortality in Australia: A critical analysis.
    Pathirana T; Sequeira R; Del Mar C; Dickinson JA; Armstrong BK; Bell KJL; Glasziou P
    Cancer Epidemiol; 2022 Apr; 77():102093. PubMed ID: 35026706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
    Hammarsten J; Högstedt B
    Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidentally Detected Adenocarcinoma Prostate in Transurethral Resection of Prostate Specimens: a Hospital Based Study from India.
    Varghese J; Kuruvilla PM; Mehta N; Rathore RS; Babu M; Bansal D; Pillai B; Sam MP; Krishnamorthy H
    Asian Pac J Cancer Prev; 2016; 17(4):2255-8. PubMed ID: 27221926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of high-grade prostatic intraepithelial neoplasia in transurethral resection specimens.
    Pacelli A; Bostwick DG
    Urology; 1997 Sep; 50(3):355-9. PubMed ID: 9301697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in case mix and treatment patterns in prostate cancer in Saskatchewan during the prostate specific antigen testing era.
    Tonita JM; Skarsgard D; Muhajarine N
    Cancer Causes Control; 2009 Mar; 20(2):201-9. PubMed ID: 18825504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidental detection of population-based prostate cancer incidence rates through transurethral resection of the prostate.
    Merrill RM; Wiggins CL
    Urol Oncol; 2002; 7(5):213-9. PubMed ID: 12644219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rising incidence of prostate cancer in Scotland: increased risk or increased detection?
    Brewster DH; Fraser LA; Harris V; Black RJ
    BJU Int; 2000 Mar; 85(4):463-72; discussion 472-3. PubMed ID: 10691826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of transurethral resection of the prostate in population-based prostate cancer incidence rates.
    Merrill RM; Feuer EJ; Warren JL; Schussler N; Stephenson RA
    Am J Epidemiol; 1999 Oct; 150(8):848-60. PubMed ID: 10522656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diminishing role of transurethral resection of the prostate.
    Merrill RM; Hunter BD
    Ann Surg Oncol; 2010 May; 17(5):1422-8. PubMed ID: 20091426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer in Denmark 1978-2009--trends in incidence and mortality.
    Outzen M; Brasso K; Martinussen N; Christensen J; Tjønneland A; Friis S; Olsen A
    Acta Oncol; 2013 May; 52(4):831-6. PubMed ID: 22809166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics.
    Pakzad R; Rafiemanesh H; Ghoncheh M; Sarmad A; Salehiniya H; Hosseini S; Sepehri Z; Afshari-Moghadam A
    Asian Pac J Cancer Prev; 2016; 17(2):839-43. PubMed ID: 26925689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and factors predicting the detection of prostate cancer after transurethral resection of the prostate for clinically benign disease.
    Bright EA; Manuel C; Goddard JC; Khan MA
    Urol Int; 2009; 83(2):171-4. PubMed ID: 19752612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate cancer trends in Canada: rising incidence or increased detection?
    Levy IG; Gibbons L; Collins JP; Perkins DG; Mao Y
    CMAJ; 1993 Sep; 149(5):617-24. PubMed ID: 8364818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing presentation of prostate cancer in a UK population--10 year trends in prostate cancer risk profiles in the East of England.
    Greenberg DC; Wright KA; Lophathanon A; Muir KR; Gnanapragasam VJ
    Br J Cancer; 2013 Oct; 109(8):2115-20. PubMed ID: 24071596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of systematic prostate biopsy on prostate cancer incidence in men with symptomatic benign prostatic hyperplasia undergoing transurethral resection of the prostate.
    Ornstein DK; Rao GS; Smith DS; Andriole GL
    J Urol; 1997 Mar; 157(3):880-3; discussion 883-4. PubMed ID: 9072591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application value of diagnostic TURP for patients with serum PSA abnormality].
    Yuan J; Zhao H; Wu B
    Zhonghua Nan Ke Xue; 2013 Nov; 19(11):999-1002. PubMed ID: 24341094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palliative transurethral prostate resection for bladder outlet obstruction in patients with locally advanced prostate cancer.
    Crain DS; Amling CL; Kane CJ
    J Urol; 2004 Feb; 171(2 Pt 1):668-71. PubMed ID: 14713783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.